Xenon Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 02/17/2026 | 8.92 M | $399.81 M | 0.02% | 11.26% |
| AVORO CAPITAL ADVISORS LLC | 03/16/2026 | 5.42 M | $243.12 M | 0.45% | 6.84% |
| BLACKROCK, INC. | 02/12/2026 | 5.10 M | $228.59 M | 6.90% | 6.44% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 4.76 M | $213.56 M | 31.99% | 6.01% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/17/2026 | 4.54 M | $203.42 M | 8.86% | 5.73% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 4.08 M | $183.11 M | 3.55% | 5.15% |
| CAPITAL INTERNATIONAL INVESTORS | 02/11/2026 | 3.41 M | $153.06 M | 7.34% | 4.31% |
| POLAR CAPITAL HOLDINGS PLC | 02/17/2026 | 2.47 M | $110.51 M | -3.18% | 3.11% |
| BRAIDWELL LP | 02/17/2026 | 1.83 M | $81.80 M | -49.37% | 2.30% |
| COMMODORE CAPITAL LP | 02/17/2026 | 1.80 M | $80.68 M | -33.33% | 2.27% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 1.59 M | $71.43 M | -3.66% | 2.01% |
| JPMORGAN CHASE & CO | 02/11/2026 | 1.49 M | $66.96 M | 6.79% | 1.89% |
| STATE STREET CORP | 02/13/2026 | 1.49 M | $66.90 M | 1.78% | 1.88% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.32 M | $59.22 M | 37.76% | 1.67% |
| JENNISON ASSOCIATES LLC | 01/30/2026 | 1.29 M | $57.91 M | 13.81% | 1.63% |
| HOLOCENE ADVISORS, LP | 02/17/2026 | 1.28 M | $57.46 M | -35.14% | 1.62% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 1.25 M | $56.03 M | -10.71% | 1.58% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 02/11/2026 | 1.23 M | $54.98 M | 1.72% | 1.55% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/13/2026 | 1.06 M | $47.52 M | 58.18% | 1.34% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 952.68 K | $42.69 M | -2.53% | 1.20% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 862.30 K | $38.65 M | 1,968.26% | 1.09% |
| SIREN, L.L.C. | 02/13/2026 | 812.76 K | $36.43 M | 0.00% | 1.03% |
| FIRST TURN MANAGEMENT, LLC | 02/13/2026 | 799.74 K | $35.84 M | 0.00% | 1.01% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/17/2026 | 787.79 K | $35.31 M | -7.51% | 0.99% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 758.06 K | $33.98 M | 8.93% | 0.96% |
| ABRDN PLC | 01/16/2026 | 750.29 K | $33.63 M | 29.55% | 0.95% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 696.05 K | $31.20 M | -3.42% | 0.88% |
| FIERA CAPITAL CORP | 02/11/2026 | 686.06 K | $30.75 M | 31.93% | 0.87% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 685.10 K | $30.71 M | -17.96% | 0.86% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 680.47 K | $30.50 M | 3.22% | 0.86% |
| FEDERATED HERMES, INC. | 02/12/2026 | 672.24 K | $30.13 M | 189.13% | 0.85% |
| VANGUARD GROUP INC | 01/29/2026 | 664.64 K | $29.79 M | -21.93% | 0.84% |
| CAPITAL WORLD INVESTORS | 02/11/2026 | 655.74 K | $29.39 M | 0.00% | 0.83% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 635.06 K | $28.46 M | -54.11% | 0.80% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 625.99 K | $28.01 M | -50.42% | 0.79% |
| LOOMIS SAYLES & CO L P | 02/12/2026 | 612.03 K | $27.43 M | -4.46% | 0.77% |
| BARCLAYS PLC | 02/13/2026 | 600.96 K | $26.94 M | 439.95% | 0.76% |
| VESTAL POINT CAPITAL, LP | 02/17/2026 | 600.00 K | $26.89 M | -45.45% | 0.76% |
| 02/17/2026 | 597.09 K | $26.76 M | 100.00% | 0.75% | |
| CALIGAN PARTNERS LP | 02/17/2026 | 549.70 K | $24.64 M | 100.00% | 0.69% |
| CALIGAN PARTNERS LP | 02/17/2026 | 549.67 K | $24.64 M | 23.64% | 0.69% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/19/2026 | 547.61 K | $24.55 M | -8.60% | 0.69% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/17/2026 | 542.02 K | $24.29 M | 0.00% | 0.68% |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 02/06/2026 | 532.74 K | $23.88 M | -4.32% | 0.67% |
| BIOIMPACT CAPITAL LLC | 02/17/2026 | 485.62 K | $21.77 M | -3.53% | 0.61% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 452.15 K | $20.26 M | -0.41% | 0.57% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 447.20 K | $20.04 M | 6.58% | 0.56% |
| NORTHERN TRUST CORP | 02/17/2026 | 438.71 K | $19.66 M | -11.93% | 0.55% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 436.74 K | $19.57 M | 100.00% | 0.55% |
| CANDRIAM S.C.A. | 04/30/2026 | 417.40 K | $18.71 M | 5.24% | 0.53% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Xenon Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 309 institutional investors and hedge funds held shares of Xenon Pharmaceuticals Inc. The most heavily invested institutionals were:
Pictet Asset Management Holding SA: 679,709
abrdn plc: 609,929
Candriam S.C.A.: 476,494
Bank of New York Mellon Corp: 396,138
Nuveen, LLC: 250,036
NAN FUNG TRINITY (HK) Ltd: 247,765
106.57% of Xenon Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 90.59 M shares in the last 24 months. This purchase volume represents approximately $5.69 B in transactions.